OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 242-251
Open Access | Times Cited: 12
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 242-251
Open Access | Times Cited: 12
Showing 12 citing articles:
Refining MR-guided thermal ablation for HCC within the Milan criteria: a decade of clinical outcomes and predictive modeling at a single institution
Fuqun Wei, Peixin Huang, Bing Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Fuqun Wei, Peixin Huang, Bing Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Celecoxib as a Potential Treatment for Hepatocellular Carcinoma in Populations Exposed to High PFAS Levels
Boshi Sun, Yuqiao Zhao, Shifeng Yang, et al.
Journal of Hazardous Materials (2025) Vol. 489, pp. 137613-137613
Closed Access
Boshi Sun, Yuqiao Zhao, Shifeng Yang, et al.
Journal of Hazardous Materials (2025) Vol. 489, pp. 137613-137613
Closed Access
A Chemotherapy Response-Related Gene Signature and DNAJC8 as Key Mediators of Hepatocellular Carcinoma Progression and Drug Resistance
Yan Ye, Yanmei Zeng, Shan Huang, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 579-595
Open Access
Yan Ye, Yanmei Zeng, Shan Huang, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 579-595
Open Access
Decoding Genomic Diversity to Guide Tumor Lesion‐Specific Treatment of Multifocal Hepatocellular Carcinoma
Kenji Amemiya, Yosuke Hirotsu, Yuji Iimuro, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Kenji Amemiya, Yosuke Hirotsu, Yuji Iimuro, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
A nomogram based on PNI and preoperative TACE can predict overall survival in patients with larger than 2 cm HCC after hepatectomy
Huizhi Zhang, Chunyu Zhang, Run Hu, et al.
Updates in Surgery (2025)
Closed Access
Huizhi Zhang, Chunyu Zhang, Run Hu, et al.
Updates in Surgery (2025)
Closed Access
Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma
Hiroyuki Suzuki, Hideki Iwamoto, Toshimitsu Tanaka, et al.
Hepatology International (2023) Vol. 18, Iss. 2, pp. 610-622
Open Access | Times Cited: 8
Hiroyuki Suzuki, Hideki Iwamoto, Toshimitsu Tanaka, et al.
Hepatology International (2023) Vol. 18, Iss. 2, pp. 610-622
Open Access | Times Cited: 8
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study
Jonathan Abdelmalak, Simone I. Strasser, Natalie LY Ngu, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5741-5741
Open Access | Times Cited: 7
Jonathan Abdelmalak, Simone I. Strasser, Natalie LY Ngu, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5741-5741
Open Access | Times Cited: 7
[A risk scoring model based on M2 macrophage-related genes for predicting prognosis of HBV-related hepatocellular carcinoma].
P Liu, Li Li, Liu X, et al.
PubMed (2024) Vol. 44, Iss. 5, pp. 827-840
Closed Access | Times Cited: 1
P Liu, Li Li, Liu X, et al.
PubMed (2024) Vol. 44, Iss. 5, pp. 827-840
Closed Access | Times Cited: 1
Impact of bile leak on the prognosis of patients with hepatocellular carcinoma who have undergone liver resection
Hidetoshi Gon, Shohei Komatsu, Hirotoshi Soyama, et al.
Langenbeck s Archives of Surgery (2024) Vol. 409, Iss. 1
Closed Access | Times Cited: 1
Hidetoshi Gon, Shohei Komatsu, Hirotoshi Soyama, et al.
Langenbeck s Archives of Surgery (2024) Vol. 409, Iss. 1
Closed Access | Times Cited: 1
The immune inductive role of hepatic arterial infusion chemotherapy prior to atezolizumab plus bevacizumab combination therapy in hepatocellular carcinoma
Hiroyuki Suzuki, Miwa Sakai, Hideki Iwamoto, et al.
Gastro Hep Advances (2024) Vol. 3, Iss. 4, pp. 506-509
Open Access | Times Cited: 1
Hiroyuki Suzuki, Miwa Sakai, Hideki Iwamoto, et al.
Gastro Hep Advances (2024) Vol. 3, Iss. 4, pp. 506-509
Open Access | Times Cited: 1
Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
Tianying Ren, Xu Hou, Xin Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21906-e21906
Open Access | Times Cited: 3
Tianying Ren, Xu Hou, Xin Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21906-e21906
Open Access | Times Cited: 3
肝細胞癌に対するatezolizumab＋bevacizumab併用療法後に出現した下垂体性副腎皮質機能低下症の3症例
Etsuko Moriyama, Hideki Iwamoto, Takashi Niizeki, et al.
Kanzo (2024) Vol. 65, Iss. 1, pp. 37-44
Open Access
Etsuko Moriyama, Hideki Iwamoto, Takashi Niizeki, et al.
Kanzo (2024) Vol. 65, Iss. 1, pp. 37-44
Open Access
Impact of bile leak on the prognosis of patients with hepatocellular carcinoma who have undergone liver resection
Hidetoshi Gon, Shohei Komatsu, Hirotoshi Soyama, et al.
Research Square (Research Square) (2024)
Open Access
Hidetoshi Gon, Shohei Komatsu, Hirotoshi Soyama, et al.
Research Square (Research Square) (2024)
Open Access
